MN

Mallinckrodt

- OTC:MNKKQ
Last Updated 2024-04-19

LinkedIn Profile

Access Mallinckrodt historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
otc:mnkkq 3192 Apr 14th, 2024 12:00AM Mallinckrodt Pharmaceuticals 74K 3312 Open Apr 14th, 2024 01:59AM Apr 14th, 2024 01:59AM At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. Open Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis Open College Business & Technology Park Dublin, Ireland IE Mallinckrodt
otc:mnkkq 86145 Apr 14th, 2024 12:00AM Sucampo Pharmaceuticals, Inc. 2.8K 39.00 Open Apr 14th, 2024 01:59AM Apr 14th, 2024 01:59AM Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG. Open Open 805 King Farm Boulevard, Suite 550 Rockville MD US 20850 Mallinckrodt
otc:mnkkq 86145 Apr 13th, 2024 12:00AM Sucampo Pharmaceuticals, Inc. 2.8K 39.00 Open Apr 13th, 2024 01:20AM Apr 13th, 2024 01:39PM Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG. Open Open 805 King Farm Boulevard, Suite 550 Rockville MD US 20850 Mallinckrodt
otc:mnkkq 3192 Apr 13th, 2024 12:00AM Mallinckrodt Pharmaceuticals 74K 3312 Open Apr 13th, 2024 01:20AM Apr 13th, 2024 01:39PM At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. Open Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis Open College Business & Technology Park Dublin, Ireland IE Mallinckrodt
otc:mnkkq 3192 Apr 12th, 2024 12:00AM Mallinckrodt Pharmaceuticals 74K 3309 Open Apr 12th, 2024 01:31AM Apr 12th, 2024 10:40AM At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. Open Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis Open College Business & Technology Park Dublin, Ireland IE Mallinckrodt
otc:mnkkq 86145 Apr 12th, 2024 12:00AM Sucampo Pharmaceuticals, Inc. 2.8K 39.00 Open Apr 12th, 2024 01:31AM Apr 12th, 2024 10:40AM Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG. Open Open 805 King Farm Boulevard, Suite 550 Rockville MD US 20850 Mallinckrodt
otc:mnkkq 3192 Apr 11th, 2024 12:00AM Mallinckrodt Pharmaceuticals 74K 3311 Open Apr 11th, 2024 03:42AM Apr 11th, 2024 01:22PM At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. Open Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis Open College Business & Technology Park Dublin, Ireland IE Mallinckrodt
otc:mnkkq 86145 Apr 11th, 2024 12:00AM Sucampo Pharmaceuticals, Inc. 2.8K 39.00 Open Apr 11th, 2024 03:42AM Apr 11th, 2024 01:22PM Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG. Open Open 805 King Farm Boulevard, Suite 550 Rockville MD US 20850 Mallinckrodt
otc:mnkkq 3192 Apr 10th, 2024 12:00AM Mallinckrodt Pharmaceuticals 74K 3308 Open Apr 10th, 2024 01:27AM Apr 10th, 2024 07:27PM At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. Open Specialty Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, and Extracorporeal Photopheresis Open College Business & Technology Park Dublin, Ireland IE Mallinckrodt
otc:mnkkq 86145 Apr 10th, 2024 12:00AM Sucampo Pharmaceuticals, Inc. 2.8K 39.00 Open Apr 10th, 2024 01:27AM Apr 10th, 2024 07:27PM Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG. Open Open 805 King Farm Boulevard, Suite 550 Rockville MD US 20850 Mallinckrodt

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.